Stryker SYK
NYSE SYK
$275.50 -0.93 (-0.34%)
As of: Sep 9, 2026 · 3:59 PM EDT

Stryker (SYK) Non-Current Assets (2009 - 2026)

Stryker's (SYK) quarterly Non-Current Assets came in at $33.5 billion in Q2 2026, up 0.55% year-over-year from $33.3 billion in Q2 2025, and up 1.7% quarter-over-quarter from $33.0 billion in Q1 2026.

Analysis

Stryker (SYK) Non-Current Assets (2009 - 2026) Analysis & Trends

Stryker (SYK) has reported Non-Current Assets for 18 consecutive years, with $33.5 billion the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Non-Current Assets rose 0.55% year-over-year to $33.5 billion in Q2 2026; TTM through Jun 2026 was $132.9 billion, a 7.53% increase from a year earlier, with the FY2025 full-year figure at $33.1 billion, up 17.65% from the prior year.
  • Non-Current Assets was $33.5 billion for Q2 2026 at Stryker, up from $33.0 billion in the prior quarter.
  • Over five years, Non-Current Assets peaked at $33.5 billion in Q2 2026 and troughed at $26.6 billion in Q4 2022.
  • A 5-year average of $29.3 billion and a median of $27.5 billion in 2024 frame the typical range for Non-Current Assets.
  • Across the five-year window, Non-Current Assets fell 2.69% in 2023 and grew 21.26% in 2025, its largest moves.
  • Over 5 years, Non-Current Assets stood at $26.6 billion in 2022, then grew by 2.95% to $27.4 billion in 2023, then advanced by 2.66% to $28.1 billion in 2024, then gained by 17.65% to $33.1 billion in 2025, then climbed by 1.28% to $33.5 billion in 2026.
  • The last three Non-Current Assets figures came in at $33.5 billion (Q2 2026), $33.0 billion (Q1 2026), and $33.1 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 84.70 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 11.33 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 68.92 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 33.51 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 37.24 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 7.05 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 24.47 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 2.37 Bn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 8.29 Bn
10 Zimmer Biomet Holdings 18.20 Bn 17.79 Bn 1.54 Bn 17.70 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 33.51 Bn
Mar 31, 2026 32.95 Bn
Dec 31, 2025 33.09 Bn
Sep 30, 2025 33.35 Bn
Jun 30, 2025 33.33 Bn
Mar 31, 2025 32.98 Bn
Dec 31, 2024 28.12 Bn
Sep 30, 2024 29.16 Bn
Jun 30, 2024 27.49 Bn
Mar 31, 2024 27.51 Bn
Dec 31, 2023 27.39 Bn
Sep 30, 2023 27.00 Bn
Jun 30, 2023 27.26 Bn
Mar 31, 2023 26.68 Bn
Dec 31, 2022 26.61 Bn
Sep 30, 2022 26.67 Bn
Jun 30, 2022 27.21 Bn
Mar 31, 2022 27.41 Bn
Dec 31, 2021 24.61 Bn
Sep 30, 2021 24.69 Bn